SYNTA PHARMACEUTICALS CORP 4
4 · SYNTA PHARMACEUTICALS CORP · Filed Oct 6, 2015
Insider Transaction Report
Form 4
Vukovic Vojo
SVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-10-02+132,300→ 132,300 totalExercise: $1.76Exp: 2025-10-02→ Common Stock (132,300 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares on October 2, 2016 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.